ReviewBiomimetics (Basel, Switzerland)2025
Bioprinted Scaffolds for Biomimetic Applications: A State-of-the-Art Technology.
Review in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Critical Systematic Review of 3D Bioprinting in Biomedicine.International journal of molecular sciences · 2025Pooled it
- The Next Phase of 3D Bioprinting: AI-Native Systems-A Narrative Review.Journal of functional biomaterials · 2026Review
- From Nature to Innovation: Exploring Natural Biopolymers in 3D Bioprinting for Bone Regeneration.ACS omega · 2026Article
- Bio-Inspired 3D-Printed Polymeric Sheets for Orthoses: Predictive Modeling of Mechanical Integrity and Moisture Absorption.Biomimetics (Basel, Switzerland) · 2026Article
- Stimuli-responsive 4D-bioprinted constructs for musculoskeletal tissue regeneration: Shape-morphing mechanisms, cell-laden bioink engineering, and preclinical outcomes.Regenerative therapy · 2026Review
- Additive Manufacturing of Engineered Tissue Constructs: Current Strategies and Future Directions.Bioengineering (Basel, Switzerland) · 2026Review
- Advanced additive manufacturing in orthopedics: a comprehensive review of biomaterials, structural design, biological functions and clinical technology applications.RSC advances · 2026Review
- Biomaterials in personalized drug delivery: innovations, challenges, and future directions.PeerJ · 2026Review
- Biomimetic Strategies for Bone Regeneration: Smart Scaffolds and Multiscale Cues.Biomimetics (Basel, Switzerland) · 2025Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review emphasizes the latest developments in bioprinted scaffolds in tissue engineering, with a focus on their biomimetic applications. The accelerated pace of development of 3D bioprinting technologies has transformed the ability to fabricate scaffolds with the potential to replicate the structure and function of native tissues. Bioprinting methods such as inkjet, extrusion-based, laser-assisted, and digital light processing (DLP) approaches have the potential to fabricate complex, multi-material structures with high precision in geometry, material composition, and cellular microenvironments. Incorporating biomimetic design principles to replicate the mechanical and biological behaviors of native tissues has been of major research interest. Scaffold geometries that support cell adhesion, growth, and differentiation essential for tissue regeneration are mainly of particular interest. The review also deals with the development of bioink, with an emphasis on the utilization of natural, synthetic, and composite materials for enhanced scaffold stability, printability, and biocompatibility. Rheological characteristics, cell viability, and the utilization of stimuli-responsive bioinks are also discussed in detail. Their utilization in bone, cartilage, skin, neural, and cardiovascular tissue engineering demonstrates the versatility of bioprinted scaffolds. Despite the significant advancements, there are still challenges that include achieving efficient vascularization, long-term integration with host tissues, and scalability. The review concludes by underlining future trends such as 4D bioprinting, artificial intelligence-augmented scaffold design, and the regulatory and ethical implications involved in clinical translation. By considering these challenges in detail, this review provides insight into the future of bioprinted scaffolds in regenerative medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.